CRENESSITY Trademark

Trademark Overview

On Wednesday, February 14, 2024, a trademark application was filed for CRENESSITY with the United States Patent and Trademark Office. The USPTO has given the CRENESSITY trademark a serial number of 98976464. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Monday, August 25, 2025. This trademark is owned by Neurocrine Biosciences, Inc.. The CRENESSITY trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Providing medical information to patients, medical professionals in the field of congenital adrenal hyperplasia; on-line information services, namely, providing medical information to patients, medical professionals, in the field of congenital adrenal hyperplasia

Providing medical research information in the field of pharmaceuticals and clinical trials focusing on congenital adrenal hyperplasia
crenessity

General Information

Serial Number98976464
Word MarkCRENESSITY
Filing DateWednesday, February 14, 2024
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateMonday, August 25, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 26, 2024

Trademark Statements

Goods and ServicesProviding medical information to patients, medical professionals in the field of congenital adrenal hyperplasia; on-line information services, namely, providing medical information to patients, medical professionals, in the field of congenital adrenal hyperplasia
Goods and ServicesProviding medical research information in the field of pharmaceuticals and clinical trials focusing on congenital adrenal hyperplasia

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, February 14, 2024
Primary Code042
First Use Anywhere DateSaturday, December 14, 2024
First Use In Commerce DateSaturday, December 14, 2024
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, February 14, 2024
Primary Code044
First Use Anywhere DateSaturday, December 14, 2024
First Use In Commerce DateSaturday, December 14, 2024

Trademark Owner History

Party NameNeurocrine Biosciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130
Party NameNeurocrine Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Trademark Events

Event DateEvent Description
Wednesday, February 14, 2024NEW APPLICATION ENTERED
Sunday, June 16, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 15, 2024ASSIGNED TO EXAMINER
Wednesday, August 28, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 28, 2024NON-FINAL ACTION WRITTEN
Friday, November 1, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 1, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 1, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, November 20, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 26, 2024PUBLISHED FOR OPPOSITION
Tuesday, November 26, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 7, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 25, 2025SOU TEAS EXTENSION RECEIVED
Tuesday, February 25, 2025SOU EXTENSION 1 FILED
Wednesday, February 26, 2025SOU EXTENSION 1 GRANTED
Wednesday, February 26, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 20, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, March 20, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, March 20, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, April 7, 2025DIVISIONAL REQUEST RECEIVED
Monday, April 7, 2025TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, July 23, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, August 22, 2025STATEMENT OF USE PROCESSING COMPLETE
Wednesday, August 28, 2024NON-FINAL ACTION E-MAILED
Monday, April 7, 2025TEAS STATEMENT OF USE RECEIVED
Monday, November 4, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 7, 2025USE AMENDMENT FILED
Friday, August 22, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, August 22, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 25, 2025ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, August 25, 2025NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, August 22, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, August 22, 2025DIVISIONAL PROCESSING COMPLETE

Related Keywords

crenessity medical information adrenal providing congenital hyperplasia field patients professionals clinical